Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A five-microRNA signature for individualized prognosis evaluation and radiotherapy guidance in patients with diffuse lower-grade glioma.

Journal of cellular and molecular medicine - 1 Jul 2020

Zhang Jian-Hua, Hou Ruiqin, Pan Yuhualei, Gao Yuhan, Yang Ying, Tian Wenqin, Zhu Yan-Bing

Abstract excerpt

Despite the prognostic value of IDH and other gene mutations found in diffuse glioma, markers that judge individual prognosis of patients with diffuse lower-grade glioma (LGG) are still lacking. This study aims to develop an expression-based microRNA signature to provide survival and radiotherapeutic response prediction for LGG patients. MicroRNA expression profiles and relevant clinical information of LGG...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to Glioma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Isocitrate Dehydrogenase

Share to Kaplan-Meier Estimate

Share to Multivariate Analysis

Share to Neoplasm Grading

Share to Proportional Hazards Models

Share to Survival Analysis

Source

Open in PubMed Open full text

Identifiers

PMID: 32412186
DOI: 10.1111/jcmm.15377
PMCID: PMC7339211

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A five-microRNA signature for individualized prognosis evaluation and radiotherapy guidance in patients with diffuse lower-grade glioma.PMID 32412186Read ↗

Development of a Prognostic Five-Gene Signature with Radiotherapy Guidance Significance for Diffuse Lower-Grade Glioma Patients Based on Large-Scale Sequencing DataSemantic proximity Read ↗

Identification and validation of a three-gene signature as a candidate prognostic biomarker for lower grade gliomaSemantic proximity Read ↗

Gene Expression Profiling Stratifies IDH1-Mutant Glioma with Distinct Prognoses.Semantic proximity Read ↗

Gene Expression Profiling Stratifies IDH-Wildtype Glioblastoma With Distinct PrognosesSemantic proximity Read ↗

Classifying lower grade glioma cases according to whole genome gene expressionSemantic proximity Read ↗

A RNA sequencing-based six-gene signature for survival prediction in patients with glioblastomaSemantic proximity Read ↗

The Development and Validation of a Novel 71-Gene Signature for Risk Stratification and Prognosis in Lower Grade GliomaSemantic proximity Read ↗

Molecular classification of IDH-mutant glioblastomas based on gene expression profilesSemantic proximity Read ↗

Molecular characteristics of incidental lower-grade glioma for treatment decision-making.Semantic proximity Read ↗

Development and Validation of an IDH1-Associated Immune Prognostic Signature for Diffuse Lower-Grade GliomaSemantic proximity Read ↗

Prognostic Value of an Autophagy-Related Five-Gene Signature for Lower-Grade Glioma PatientsSemantic proximity Read ↗

Expression and prognostic value of microRNAs in lower-grade glioma depends on IDH1/2 status.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.